Position in BTAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$129,273
+$38,353 QoQ
Shares Held
96,473
+69.8% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,805,003 | $129,707,515 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
601,019 | $101,295,742 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
134,890 | $73,087,447 | |
| 4 | VTRS |
Viatris Inc
|
3,523,052 | $55,946,065 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,530,206 | $15,898,840 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
732,867 | $7,328,670 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
156,422 | $7,275,186 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
1,451,781 | $7,157,279 |
All Filings in BTAI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $129,273 | 96,473 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $90,920 | 56,825 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||